|
Volumn 28, Issue 2, 2010, Pages 199-202
|
Hemangiopericytoma and antiangiogenic therapy: Clinical benefit of antiangiogenic therapy (sorafenib and sunitinib) in relapsed Malignant Haemangioperyctoma /Solitary Fibrous Tumour
|
Author keywords
Antiangiogenic; Functional imaging; Sarcoma; Sorafenib; Sunitinib
|
Indexed keywords
ANTHRACYCLINE;
CISPLATIN;
DACARBAZINE;
EPIRUBICIN;
IFOSFAMIDE;
PACLITAXEL;
SORAFENIB;
SUNITINIB;
TRABECTEDIN;
ADULT;
ADVANCED CANCER;
AGED;
ANAMNESIS;
ANTIANGIOGENIC THERAPY;
ASTHENIA;
BONE PAIN;
CANCER GROWTH;
CANCER MORTALITY;
CANCER RELAPSE;
CANCER SURGERY;
CASE REPORT;
CLINICAL TRIAL;
COMPUTER ASSISTED TOMOGRAPHY;
CONTRAST ENHANCEMENT;
DISEASE COURSE;
DISEASE SEVERITY;
DRUG EFFICACY;
DRUG RESPONSE;
DRUG WITHDRAWAL;
DYSPNEA;
ECHOGRAPHY;
FEMALE;
HEMANGIOPERICYTOMA;
HUMAN;
LIVER METASTASIS;
LIVER TOXICITY;
LUNG METASTASIS;
METASTASIS;
MULTIPLE CYCLE TREATMENT;
PANCREAS;
PATIENT REFERRAL;
PELVIS;
PERITONEUM METASTASIS;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
REVIEW;
SACRUM;
SOLITARY FIBROUS TUMOR;
TUMOR GROWTH;
TUMOR VASCULARIZATION;
TUMOR VOLUME;
AGED;
ANGIOGENESIS INHIBITORS;
BENZENESULFONATES;
FATAL OUTCOME;
FEMALE;
HEMANGIOPERICYTOMA;
HUMANS;
INDOLES;
MIDDLE AGED;
NEOVASCULARIZATION, PATHOLOGIC;
PYRIDINES;
PYRROLES;
RECURRENCE;
SOLITARY FIBROUS TUMORS;
TOMOGRAPHY, X-RAY COMPUTED;
|
EID: 77952221960
PISSN: 01676997
EISSN: None
Source Type: Journal
DOI: 10.1007/s10637-009-9249-1 Document Type: Review |
Times cited : (36)
|
References (5)
|